Concepedia

Rohit Talwani

RT

Statistics

Publications

27

Citations

1.5K

H-Index

18

Active since

2002

Affiliations

University of Maryland, Baltimore(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Institute of Human Virology

Rohit Talwani is an author at University of Maryland, Baltimore specializing in infectious diseases, viral hepatitis, and virology.

ORCID

Publications per year

2002–2023

27

Publications

27

Sofosbuvir and Ribavirin for Hepatitis C Genotype 1 in Patients With Unfavorable Treatment Characteristics

A. Osinusi, Eric G. Meissner, Y.-J. Lee et al. · JAMA · 2013 · 287 citations

, , +17

Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection

Anu Osinusi, Kerry Townsend, Anita Kohli et al. · JAMA · 2015 · 203 citations · Full text

, , +17

Phase II, Randomized, Double-Blind, Multicenter Study Comparing the Safety and Pharmacokinetics of Tefibazumab to Placebo for Treatment of <i>Staphylococcus aureus</i> Bacteremia

J. John Weems, James P. Steinberg, Scott G. Filler et al. · Antimicrobial Agents and Chemotherapy · 2006 · 155 citations · Full text

, , +15

Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study

Anita Kohli, A. Osinusi, Zayani Sims et al. · The Lancet · 2015 · 151 citations

, , +16

Diagnosis and management of Lyme disease.

William F. Wright, David J. Riedel, Rohit Talwani et al. · PubMed · 2012 · 76 citations

, , +17

1–5 of 27